About Jeff Huber
Form D filings for Manifold Biotechnologies from 2022 to 2024 list Jeff Huber as director.
Jeff Huber first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jeff Huber in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeff Huber works with at each company, as listed on that company's latest Form D.
Manifold Biotechnologies, Inc. · Form D, Dec 3, 2024
JB
Jory Bell
Director
GK
Gleb Kuznetsov
Chief Executive Officer and director
PO
Pierce Ogden
Executive officer and director
SK
Steven Kafka
Director
SH
Steven Holtzman
Director